These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
660 related items for PubMed ID: 31104192
21. F-18-FDG PET-CT in children and young adults with Ewing sarcoma diagnosed in Norway during 2005-2012: a national population-based study. Johnsen B, Boye K, Rosendahl K, Biermann M, Trovik C, Aukland SM. Clin Physiol Funct Imaging; 2016 Nov; 36(6):441-446. PubMed ID: 26039107 [Abstract] [Full Text] [Related]
22. Estimated cumulative radiation dose received by diagnostic imaging during staging and treatment of operable Ewing sarcoma 2005-2012. Johnsen B, Fasmer KE, Boye K, Rosendahl K, Trovik C, Biermann M, Aukland SM. Pediatr Radiol; 2017 Jan; 47(1):82-88. PubMed ID: 27815616 [Abstract] [Full Text] [Related]
23. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT. Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Hell J Nucl Med; 2019 Jan; 22(1):6-9. PubMed ID: 30843003 [Abstract] [Full Text] [Related]
24. Diagnostic Accuracy of 18F-FDG PET/CT in the Staging and Assessment of Response to Chemotherapy in Children With Ewing Sarcoma. Ruggiero A, Lanni V, Librizzi A, Maurizi P, Attinà G, Mastrangelo S, Giordano A, Riccardi R. J Pediatr Hematol Oncol; 2018 May; 40(4):277-284. PubMed ID: 29620679 [Abstract] [Full Text] [Related]
25. Recurrent Metastatic Ewing Sarcoma Involving Only in the Muscles of Extremities Shown on FDG PET/CT. Fleury AS, Zhuang H. Clin Nucl Med; 2024 Jun 01; 49(6):589-591. PubMed ID: 38537215 [Abstract] [Full Text] [Related]
26. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy. Teagle AR, Barton H, Charles-Edwards E, Dizdarevic S, Chevassut T. Acta Radiol; 2017 Dec 01; 58(12):1476-1484. PubMed ID: 28382828 [Abstract] [Full Text] [Related]
27. Staging and follow-up of a Ewing sarcoma patient using 18F-FDG PET/CT. Garcia JR, Castañeda A, Morales La Madrid A, Bassa P, Soler M, Riera E. Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018 Dec 01; 37(6):387-389. PubMed ID: 29107752 [No Abstract] [Full Text] [Related]
29. FDG PET scan in a primitive neuroectodermal tumor. Musana KA, Raja S, Cangelosi CJ, Lin YG. Ann Nucl Med; 2006 Apr 01; 20(3):221-5. PubMed ID: 16715954 [Abstract] [Full Text] [Related]
30. Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of Kidney With Inferior Vena Cava Thrombus: Findings on 18F-FDG PET/CT. Tripathy S, Shamim SA, Chellapuram S, Barwad A, Rastogi S. Clin Nucl Med; 2020 Feb 01; 45(2):e103-e105. PubMed ID: 31876802 [Abstract] [Full Text] [Related]
31. Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma. Raciborska A, Bilska K, Drabko K, Michalak E, Chaber R, Pogorzała M, Połczyńska K, Sobol G, Wieczorek M, Muszyńska-Rosłan K, Rychlowska-Pruszyńska M, Rodriguez-Galindo C, Dziuk M. Clin Transl Oncol; 2016 Feb 01; 18(2):189-95. PubMed ID: 26250765 [Abstract] [Full Text] [Related]
32. Diagnostic accuracy of 18F-FDG PET/CT for detecting recurrence in patients with primary skeletal Ewing sarcoma. Sharma P, Khangembam BC, Suman KC, Singh H, Rastogi S, Khan SA, Bakhshi S, Thulkar S, Bal C, Malhotra A, Kumar R. Eur J Nucl Med Mol Imaging; 2013 Jul 01; 40(7):1036-43. PubMed ID: 23558689 [Abstract] [Full Text] [Related]
33. Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors. Al-Bulushi NK, Abouzied ME. Nucl Med Commun; 2016 Jun 01; 37(6):583-8. PubMed ID: 26813992 [Abstract] [Full Text] [Related]
35. 18F-FDG PET/CT Radiomic Analysis with Machine Learning for Identifying Bone Marrow Involvement in the Patients with Suspected Relapsed Acute Leukemia. Li H, Xu C, Xin B, Zheng C, Zhao Y, Hao K, Wang Q, Wahl RL, Wang X, Zhou Y. Theranostics; 2019 Jun 01; 9(16):4730-4739. PubMed ID: 31367253 [Abstract] [Full Text] [Related]
36. Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET/CT and circulating tumor DNA. Schmidkonz C, Krumbholz M, Atzinger A, Cordes M, Goetz TI, Prante O, Ritt P, Schaefer C, Agaimy A, Hartmann W, Rössig C, Fröhlich B, Bäuerle T, Dirksen U, Kuwert T, Metzler M. Eur J Nucl Med Mol Imaging; 2020 Jun 01; 47(6):1564-1575. PubMed ID: 31853559 [Abstract] [Full Text] [Related]
39. Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. Völker T, Denecke T, Steffen I, Misch D, Schönberger S, Plotkin M, Ruf J, Furth C, Stöver B, Hautzel H, Henze G, Amthauer H. J Clin Oncol; 2007 Dec 01; 25(34):5435-41. PubMed ID: 18048826 [Abstract] [Full Text] [Related]
40. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography. Ak I, Sivrikoz MC, Entok E, Vardareli E. Eur J Cardiothorac Surg; 2010 Apr 01; 37(4):792-6. PubMed ID: 20015657 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]